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In normal human melanocytes various mitogens
activate the mitogen-activated protein kinases
ERK1/2 and the downstream transcription factor
CREB (Ca2+/cAMP response element binding
protein). Endothelin-1, basic ®broblast growth
factor, and a-melanotropin interact synergistically to
stimulate human melanocyte proliferation. The
former two mitogens phosphorylated ERK1/2, its
substrate p90rsk, and CREB. a-Melanotropin, forsko-
lin, or dibutyryl cAMP failed to phosphorylate any
of those targets, however. The concomitant presence
of endothelin-1, basic ®broblast growth factor, and
a-melanotropin signi®cantly potentiated CREB
phosphorylation. The mitogen-induced phosphoryl-
ation of p90rsk and CREB was dependent on ERK1/2
activation, and was mediated by intracellular calcium
mobilization and by protein kinase C and tyrosine
kinase activation, but not by activation of the
cAMP-dependent protein kinase A. Exposure of mel-
anocytes to ultraviolet radiation B resulted in the
phosphorylation of the stress-induced mitogen-
activated protein kinases p38 and JNK/SAPK, but
not ERK1/2. Ultraviolet radiation B induced the
phosphorylation of CREB via a pathway that was
partially dependent on p38, but had no effect on
p90rsk or ERK1/2. Therefore, in human melanocytes,
CREB is a common downstream target for distinct
effectors that are involved in either mitogenic signal-
ing or stress signaling initiated by ultraviolet radi-
ation B. Key words: CREB/endothelin-1/MAP kinases/
a-melanotropin/ultraviolet radiation. J Invest Dermatol
118:316±322, 2002
N
ormal human melanocytes require the crosstalk of
different signaling pathways in order to proliferate
in vitro. Basic ®broblast growth factor (bFGF),
which is synthesized by keratinocytes, interacts
synergistically with agents that elevate cAMP to
stimulate human melanocyte proliferation (Halaban et al, 1988;
Abdel-Malek et al, 1992). bFGF binds and activates speci®c tyrosine
kinase receptors (Coughlin et al, 1988). Endothelin-1 (ET-1),
another keratinocyte-derived mitogen for melanocytes, interacts
synergistically with cholera toxin to induce melanocyte prolifera-
tion (Yada et al, 1991; Imokawa et al, 1992). ET-1 elicits its
biologic effects on human melanocytes by binding to G-protein
coupled endothelin-B receptors (Tada et al, 1998). Activation of
those receptors stimulates protein kinase C (PKC) and nonreceptor
tyrosine kinases, and increases intracellular calcium mobilization
and inositol triphosphate formation (Griendling et al, 1989; Yada et
al, 1991; Pribnow et al, 1992; Simonson and Herman, 1993;
Imokawa et al, 1996). a-Melanotropin (a-MSH), synthesized by
melanocytes and keratinocytes, binds to the melanocortin 1
receptor, a G-protein coupled receptor that is expressed on
melanocytes, and results in stimulation of cAMP formation
(Schauer et al, 1994; Abdel-Malek et al, 1995; Chakraborty et al,
1996; Suzuki et al, 1996). bFGF, ET-1, and a-MSH interact
synergistically to induce human melanocyte proliferation (Swope et
al, 1995).
Activation of tyrosine kinase receptors such as c-kit, c-Met, and
bFGF receptors, as well as stimulation of PKC, e.g. by phorbol 12-
myristate 13-acetate (TPA) or ET-1, results in activation of the
mitogen-activated protein (MAP) kinases ERK1/2 in human
melanocytes (Funasaka et al, 1992). ERK1/2 are 42 and 44 kDa
proteins, respectively, that are activated upon phosphorylation of
threonine 192 and tyrosine 194 by the upstream kinase MEK
(Boulton et al, 1991; Moodie et al, 1993). Activation of ERK1/2 is
critical for the mitogenic response of melanocytes. Failure to
activate these kinases is evident in terminally differentiated
melanocytes that are refractory to the mitogenic effect of TPA
and express inactive ERK1/2 (Medrano et al, 1994). In human
melanocytes, activation of ERK1/2 by growth factors such as
bFGF, ET-1, hepatocyte growth factor, or stem cell factor is
associated with activation of p90rsk and the transcription factor
Ca2+/cAMP response element binding protein (CREB), suggesting
that p90rsk acts as a CREB kinase (BoÈhm et al, 1995).
Phosphorylation of CREB at Ser 133 is required for transcriptional
activation of genes containing a cAMP response element (Gonzalez
and Montminy, 1989; Sheng et al, 1991; Frank and Greenberg,
1994). CREB phosphorylation can also be induced independently
of ERK1/2 or p90rsk phosphorylation, such as in the response of
PC12 cells to hypoxia or of HeLa cells to ultraviolet (UV) C
radiation, via a pathway that involves the activation of the MAP
kinase p38 (Iordanov et al, 1997; Beitner-Johnson and Millhorn,
1998).
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We hereby report on the role of ET-1, bFGF, and a-MSH and
of UVB radiation in the activation of various MAP kinases, p90rsk,
and CREB in human melanocytes. Our results suggest that,
whereas the signaling pathways that are mediated by PKC, tyrosine
kinase, and intracellular Ca2+ mobilization converge on the
activation of p90rsk and CREB, the cAMP-mediated pathway
modulates different downstream effectors that are yet to be
identi®ed. Interestingly, CREB phosphorylation is also induced
by exposure of melanocytes to UVB in the absence of ERK1/2 or
p90rsk phosphorylation. Irradiation with UVB induces robust
phosphorylation of p38 as well as JNK/SAPK. Therefore, in
human melanocytes, phosphorylation of CREB occurs by at least
two distinct pathways: one is mitogen induced and dependent on
ERK1/2 and p90rsk, and the other is stress induced, independent of
these two kinases, and dependent on p38 and possibly JNK/SAPK.
MATERIALS AND METHODS
Cell culture Primary cultures of normal human melanocytes were
derived from neonatal foreskins, as previously described (Swope et al,
1995). Each foreskin was individually processed, and epidermal cell
suspension, containing melanocytes, was prepared in the growth medium
described by Medrano and Nordlund (1990); and plated in T-25 cm2
¯ask. The growth medium consists of MCDB 153 supplemented with
4% heat-inactivated fetal bovine serum, 5 mg per ml insulin, 1 mg per ml
a-tocopherol, 0.6 ng per ml human recombinant bFGF, 8 nM TPA, and
13 mg per ml bovine pituitary extract (BPE). The cultures were
maintained in a humidi®ed incubator containing 5% CO2 at 37°C.
For all experiments, melanocyte cultures maintained for less than 10
passages were used. ET-1, bFGF, and a-MSH were purchased from
Sigma Chemical (St. Louis, MO). To determine the effects of ET-1 and
a-MSH, melanocytes were maintained in a growth medium lacking
TPA and BPE for 2±3 d prior to, and for the duration of, the
experiments. BPE contains micromolar concentrations of a-MSH; thus it
was omitted from the growth medium in order to determine the effect
of exogenously added melanotropins (Abdel-Malek et al, 1995). TPA
downregulates the receptors for ET-1 (Resink et al, 1990); thus it was
removed from the culture medium to ensure optimal response of
melanocytes to ET-1.
Procedure for Western blot analysis of CREB, p90rsk, ERK1/2, p38,
and JNK/SAPK Melanocytes were plated at a density of 1 3 106 cells
per 60 mm dish, in medium deprived of TPA and/or BPE. Three or
four days after plating, the depleted growth medium was replaced by
MCDB 153 without any supplements for 3±4 h and the effect of each of
the mitogens on CREB and p90rsk was determined. The cultures were
treated with 0 (control), 0.1, or 10 nM ET-1, 10 nM a-MSH, and
0.6 ng per ml bFGF, individually or in combination, for 15±90 min. To
investigate the role of the cAMP pathway, melanocytes were treated
with 1 mM forskolin, 10 nM a-MSH, 50 mM dibutyryl cAMP
(dbcAMP), or 0.1 nM ET-1 for 30 min. To investigate the role of
intracellular Ca2+ mobilization in the phosphorylation of p90rsk and
CREB, cultures were treated with 20 or 30 mM 1,2-bis(o-
aminophenoxy)ethene-N,N,N¢,N¢-tetraacetic acid (BAPTA/AM;
Figure 1. Differential effects of melanocyte-
speci®c mitogens and UVB on ERK1/2,
p90rsk, and CREB. (a) Western blot analysis for
phosphorylated ERK1/2 and total ERK1/2,
respectively, was carried out. Melanocytes were
treated with 0, 0.1, or 10 nM ET-1, 10 nM
a-MSH, 1 mM forskolin, or 0.6 ng per ml bFGF
for 30 min. The second lane represents phospho-
ERK1/2 control, and the last lane represents total
ERK1/2 control; both were provided in the
antibody kit. (b) p90rsk was detected in
melanocytes that were treated with 0, 10 nM a-
MSH and/or 0.1 nM ET-1 for 0.5, 1.5, or 3 h or
with 0.6 ng per ml bFGF for 0.5 h. (c) Expression
of phosphorylated CREB (pCREB) was
investigated in melanocytes that were treated with
0 (control), 10 nM a-MSH, 0.1 or 10 nM ET-1,
0.6 ng per ml bFGF, or a combination of all
factors, for 15 or 90 min. Expression of total
CREB was determined in melanocytes treated
with 0, 10 nM a-MSH, 0.1 nM ET-1, 1 mM
forskolin, or 8 nM TPA for 30 min. (d) Western
blot analysis was carried out for phosphorylated
CREB. Melanocytes were treated with 20 mM of
the MEK inhibitor PD 98059, 8 nM TPA,
TPA + PD 98059, 0.1 nM ET-1, ET-1 + PD
98059, for 30 min. Each of the above experiments
was carried out twice with similar ®ndings.
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Calbiochem), a chelator of intracellular Ca2+, in the presence or absence
of 0.1 nM ET-1 for 30 min. The role of PKC was determined by
treating melanocytes with 5 mM bisindolylmaleimide (Calbiochem), a
speci®c PKC inhibitor, in the presence or absence of 8 nM TPA or
0.1 nM ET-1 for 45 min. The participation of tyrosine kinase or ERK1/
2 in CREB and p90rsk phosphorylation was investigated by treating
melanocytes for 40 min with 5, 50, or 100 mM tyrphostin A25, a
tyrosine kinase inhibitor, in the presence or absence of 0.1 nM ET-1, or
with 20 mM PD 98059, a speci®c MEK inhibitor (both inhibitors were
from Calbiochem), for 30 min in the presence or absence of 0.1 nM
ET-1 or 8 nM TPA. To determine whether or not UVB induces
ERK1/2, p38, JNK/SAPK, p90rsk, or CREB phosphorylation,
melanocytes were irradiated a single time with 7, 14, 21, or 28 mJ per
cm2 UVB, as described previously (Barker et al, 1995), or treated with
ET-1, and extracted after 30 min. The role of p38 in CREB
phosphorylation was determined by treating melanocytes with 10 mM
p38 inhibitor SB 203580 immediately after irradiation with UVB, or
concomitantly with ET-1 for 30 min. The light source used is a bank of
FS20 lamps, with 75% emission in the UVB range (290±320 nm) and
25% emission in the UVA range (320±400 nm), and peak emission at
313 nm.
For detection of ERK1/2 phosphorylation, the Phospho Plus p44/42
MAP Kinase Antibody kit was used (Cell Signaling Technology,
Beverly, MS). Primary antibodies were used at 1:1000 dilution and
horseradish peroxidase antirabbit IgG was used at 1:1000 dilution. For
detection of CREB, equal amounts of protein (25±50 mg) were loaded
and separated on 10% or 12% polyacrylamide gel. Following electrophor-
esis and transblotting onto nitrocellulose membranes, the proteins were
incubated overnight at 4°C with either a rabbit polyclonal anti-rat Ser
133 phosphorylated CREB antibody or a rabbit polyclonal CREB
antibody (that recognizes total CREB) (1:5000 dilution; Upstate
Biotechnology), rabbit polyclonal IgG that recognizes p90rsk (1:200
dilution; C-21, Santa Cruz Biotechnology, Santa Cruz, CA), or rabbit
polyclonal IgG that recognizes ERK1/2 (1:3000 dilution; C-14, Santa
Cruz Biotechnology). The membranes were then reacted with horserad-
ish peroxidase anti-rabbit IgG (1:3000 dilution; Amersham Life Sciences,
Arlington Heights, IL). For detection of p38 or JNK/SAPK, 150 mg
protein were loaded on each lane and the Phospho Plus p38 MAP
Kinase or JNK/SAPK Antibody kit, respectively, was used (Cell
Signaling Technology). Both primary and horseradish peroxidase conju-
gated secondary antibodies were used at 1:1000 dilution. For all
experiments the bands were visualized by chemiluminescence using the
Renaissance kit (Dupont NEN, Boston, MA).
Rsk 1 immune complex kinase assay To con®rm that the gel
mobility shifts of p90rsk (Rsk 1) and CREB observed by Western
blotting are due to phosphorylation and activation, Rsk kinase assays
were performed. Cells were exposed to 0.1 or 10 nM ET-1 or 8 nM
TPA for 30 min at 37°C, washed with ice-cold phosphate-buffered
saline (PBS), and harvested by adding 0.3 ml of buffer A [containing
50 mM Tris (pH 7.4), 2 mM ethylenediamine tetraacetic acid, 2 mM
ethyleneglycol-bis(b-aminoethyl ether)-N,N,N¢,N¢-tetraacetic acid (EGTA),
0.5 mM sodium orthovanadate, 10 mM b-glycerophosphate, 1% Triton
X-100, 1 mM phenylmethylsulfonyl ¯uoride, 2 mg per ml leupeptin, and
2 mg per ml aprotinin]. Cell lysates were centrifuged for 10 min at
14,000 3 g at 4°C to pellet the Triton-insoluble fraction. Rsk was
immunoprecipitated from 370 to 740 mg of total protein, using 3±7 mg
of an anti-Rsk polyclonal antibody (Santa Cruz Biotechnology) in a total
volume of 1.5 ml. After the addition of 30 ml of a 50% (vol/vol)
suspension of protein G agarose beads, the reaction slurry was allowed to
rock at 4°C for 2 h. The immunoprecipitation complex was washed
three times with 0.5 ml of ice-cold fresh buffer A, and twice with
0.1 ml of kinase assay buffer (containing 20 mM MOPS, pH 7.2,
25 mM b-glycerophosphate, 5 mM EGTA, and 1 mM sodium
orthovanadate). In addition to buffer A described above, the kinase assay
reaction mixture contained ®nal concentrations of 7.5 mM MgCl2,
50 mM ATP containing 20 mCi of g[32P]-ATP (New England Nuclear,
Boston, MA), and 50 mM of CREBtide (Alpha Diagnostics, San
Antonio, TX), in a ®nal volume of 60 ml CREBtide, which corresponds
to amino acids 127±140 of CREB (KRREILSRRPSYRK) and includes
the major CREB phosphate acceptor site, Ser 133 (Ginty et al, 1994). As
a positive control for the assay, puri®ed MAPKAP kinase-2 was used
instead of cell lysate. Reactions were initiated by the addition of 10 ml of
g[32P]-ATP, and incubated for 20 min with shaking at 30°C. Duplicate
samples from each immunoprecipitation complex were assayed.
Reactions were terminated by spotting 30 ml aliquots on 1.5 3 1.5 cm
squares of Whatman p81 phosphocellulose paper followed by immersion
in 75 mM H3PO4 with gentle rocking, followed by a 5 min wash in
acetone. Filters were then air dried and subjected to liquid scintillation
counting.
RESULTS
Mitogen-induced CREB phosphorylation requires
activation of ERK1/2 Treatment of human melanocytes with
0.1 or 10 nM ET-1 or 0.6 ng per ml bFGF resulted in ERK1/2
phosphorylation (Fig 1a) (Swope et al, 1995). Treatment with
10 nM a-MSH or 1 mM forskolin did not phosphorylate ERK1/2,
however. These results were obtained using an antibody that only
detects the phosphorylated form of ERK1/2. Use of an antibody
that recognizes total ERK1/2 revealed that the levels of these
kinases in the a-MSH or forskolin treated groups were comparable
to those in the ET-1 or bFGF treated groups.
Based on previous ®ndings that p90rsk is a substrate for ERK1/2
in normal human melanocytes (BoÈhm et al, 1995), the abilities of
ET-1, bFGF, and a-MSH to phosphorylate p90rsk were compared.
Consistent with the effects of these factors on ERK1/2, ET-1 and
bFGF, but not a-MSH, induced the phosphorylation of p90rsk,
detected as a shift towards a slower mobility form of the protein
(Fig 1b). To correlate the gel mobility shifts of p90rsk with Rsk
kinase activity, an immune complex kinase assay was performed
using CREBtide as a substrate. ET-1 at 0.1 or 10 nM induced a 12-
or 27-fold increase in Rsk activity, respectively, compared to the
145-fold increase induced by 8 nM TPA (Table I).
It was reported that p90rsk serves as a CREB kinase in normal
human melanocytes (BoÈhm et al, 1995). Treatment of human
melanocytes with 0.1 or 10 nM ET-1 or 0.6 ng per ml bFGF
resulted in the phosphorylation of CREB within 15 min (Fig 1c).
The effect of ET-1 was dose dependent. Treatment with 10 nM a-
MSH, however, a concentration that induces a substantial increase
in cAMP levels, failed to induce CREB phosphorylation (Suzuki et
al, 1996). Concomitant addition of 0.1 nM ET-1, 0.6 ng per ml
bFGF, and 10 nM a-MSH had an additive effect on the
phosphorylation of CREB. The effect of ET-1 and/or bFGF was
transient, and CREB phosphorylation declined signi®cantly within
90 min of exposure of melanocytes to either mitogen. The dose-
dependent stimulation of CREB phosphorylation by ET-1 correl-
ated with the dose-dependent effects on Rsk activity (Fig 1c,
Table I). Similarly, stimulation of CREB phosphorylation by
8 nM TPA correlated with its effect on Rsk activity (Fig 1d,
Table I).
In these and subsequent experiments in which CREB phos-
phorylation was investigated, a polyclonal antibody that only
recognizes the phosphorylated form of CREB was used. Using an
antibody that recognizes the phosphorylated as well as the
unphosphorylated form of CREB revealed that the total amount
of CREB was comparable in all the groups (Fig 1c). This indicates
that the expression of phosphorylated CREB is not due to its
increased synthesis or accumulation, and that its absence is not due
to degradation.
MEK is the immediate upstream activator of ERK1/2 (Lange-
Carter et al, 1994). The effect of the MEK inhibitor PD 98059 on
Table I. Effect of ET-1 and TPA on Rsk kinase activitya
Sample
Speci®c activity
(pmol per min)
Control 0.2
0.1 nM ET 2.4
10 nM ET 5.4
8 nM TPA 29
Puri®ed MAPKAP kinase-2 170
aCells were exposed to 0.1 or 10 nM ET-1 or 8 nM TPA for 30 min, as indica-
ted. Rsk enzyme activity was measured in immune complex kinase assays using
50 mM CREBtide as a substrate, as described in Materials and Methods.
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the phosphorylation of CREB by ET-1 or TPA was determined.
Treatment of melanocytes with 20 mM PD 98059 together with
0.1 nM ET-1 or 8 nM TPA markedly inhibited the phosphoryl-
ation of CREB (Fig 1d), suggesting that stimulation of the ERK1/
2 pathway is required for the mitogen-induced activation of
CREB.
Role of the cAMP pathway in regulating the
phosphorylation of CREB Binding of a-MSH to its receptor
stimulates cAMP formation in human melanocytes (Suzuki et al,
1996). To further elucidate the role of the cAMP pathway in
regulating CREB phosphorylation, we investigated the effects of
forskolin, an activator of adenylate cyclase, and dbcAMP, a cAMP
analog that is readily transported across the cell membrane (Fig 2).
After 45 min of treatment, neither 1 mM forskolin, which induces a
marked stimulation of cAMP formation (data not shown), nor
50 mM dbcAMP phosphorylated CREB. As shown in Fig 1(c)
10 nM a-MSH had no effect, whereas 0.1 nM ET-1 induced
CREB phosphorylation. These results clearly indicate that in
melanocytes CREB phosphorylation is not induced by the cAMP
pathway.
Role of intracellular Ca2+ concentration, PKC, and tyrosine
kinases in the phosphorylation of p90rsk and CREB ET-1
increases the mobilization of intracellular calcium in normal human
melanocytes (Yada et al, 1991). Treatment of melanocytes with
30 mM BAPTA/AM, an intracellular calcium chelator, inhibited
the ET-1-induced phosphorylation of p90rsk as well as CREB
(Fig 3a, b). As PKC and tyrosine kinases are involved in the
activation of the mitogenic pathway of human melanocytes, their
role in the phosphorylation of p90rsk and its substrate CREB was
determined. ET-1 stimulates PKC as well as nonreceptor tyrosine
kinases (Imokawa et al, 1996). Treatment of normal human
melanocytes with 5 mM bisindolylmaleimide, a speci®c PKC
inhibitor, almost completely abolished the effects of 0.1 nM ET-
1 or 8 nM TPA (a speci®c activator of PKC) on p90rsk and CREB
phosphorylation (Fig 4a, b). To determine the effect of tyrosine
kinase activation on the ET-1-induced CREB phosphorylation,
normal human melanocytes were concomitantly treated with
0.1 nM ET-1 and 100 mM tyrphostin A25, a speci®c inhibitor of
tyrosine kinase. This treatment inhibited the ET-1-induced
phosphorylation of p90rsk and CREB (Fig 5a, b).
Phosphorylation of CREB in response to UVB As part of the
experiment described in Fig 1, we tested the effects of UVB on
ERK1/2 phosphorylation (Fig 6a). Irradiation of melanocytes with
a single dose equivalent to 21 or 28 mJ per cm2 UVB did not result
in phosphorylation of ERK1/2. Use of an antibody that detects
total ERK1/2 showed that UVB did not reduce the levels of these
MAP kinases, thus con®rming that lack of phosphorylation of
ERK1/2 is not due to its degradation.
The MAP kinases p38 and JNK/SAPK are phosphorylated
primarily in response to stress stimuli (Kyriakis and Avruch, 1996;
Rosette and Karin, 1996; Ono and Han, 2000). Irradiation of
human melanocytes with 21 or 28 mJ per cm2 UVB resulted in a
dose-dependent phosphorylation of p38 within 30 min after
irradiation (Fig 6b). Total p38 expression was comparable in all
lanes. Phosphorylation of p38 in melanocytes treated with 21 mJ
per cm2 continued to increase for at least 120 min after exposure to
Figure 2. Role of the cAMP pathway in the induction of CREB
phosphorylation. Melanocytes were treated with 0 (control), 0.1 nM
ET-1, 10 nM a-MSH, 1 mM forskolin, or 50 mM dbcAMP for 15 min.
Similar results were obtained in three independent experiments.
Figure 3. Role of intracellular Ca2+ mobilization in mediating
p90rsk and CREB phosphorylation. (a) p90rsk phosphorylation; (b)
CREB phosphorylation. (a) Melanocytes were treated for 30 min with
dimethylsulfoxide (DMSO) 1:150, 20 mM BAPTA/AM, 0.1 nM ET-1,
ET-1 + DMSO, ET-1 + BAPTA/AM. Arrowheads indicate the
phosphorylated form of p90rsk. (b) Two groups were treated for 30 min
with DMSO at 1:50 and 1:33 dilution to serve as diluent control, as
DMSO was used as diluent for BAPTA/AM. The remaining groups
were treated with 0.1 nM ET-1, 0.1 nM ET-1 + DMSO 1:50, 0.1 nM
ET-1 + DMSO 1:33, 20 mM BAPTA/AM, 30 mM BAPTA/AM,
0.1 nM ET-1 + 20 mM BAPTA/AM, or 0.1 nM ET-1 + 30 mM
BAPTA/AM.
Figure 4. Role of PKC activation in inducing the
phosphorylation of p90rsk and CREB. (a) p90rsk phosphorylation; (b)
CREB phosphorylation. Melanocytes were treated for 45 min with the
PKC inhibitor bisindolylmaleimide (Bis) at 5 mM, ET-1 0.1 nM, ET-
1 + 5 mM Bis, 8 nM TPA, or TPA + 5 mM Bis. This experiment was
repeated twice with similar ®ndings.
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UVB (data not shown). Treatment with ET-1 did not cause
phosphorylation of p38 (data not shown). Exposure of melanocytes
to UVB also induced the phosphorylation of JNK/SAPK (Fig 6c).
Treatment with ET-1 did not result in JNK/SAPK phosphoryl-
ation, however. CREB phosphorylation was evident in UVB-
irradiated melanocytes, but was not preceded by phosphorylation of
p90rsk (Fig 7a, b). The UVB-induced CREB phosphorylation
proved to be partially dependent on activation of p38, as treatment
of melanocytes with the p38 inhibitor SB 203580 signi®cantly
reduced this effect. These results suggest that UVB induces CREB
phosphorylation via a pathway independent of ERK1/2 and p90rsk,
and that phosphorylation of p38 and JNK/SAPK is induced by the
stress signaling pathway activated by UVB, which leads to
activation of CREB.
DISCUSSION
The synergistic interaction of multiple growth factors is a
prerequisite for stimulation of human melanocyte proliferation
in vitro, suggesting the importance of the crosstalk of different
signaling pathways, particularly the tyrosine kinase, PKC, and
cAMP/PKA pathways (Halaban et al, 1986; Abdel-Malek et al,
1992; Swope et al, 1995). Previously, it was reported that many
melanocyte-speci®c mitogens stimulate the MAP kinases ERK1/2,
suggesting a central role of these kinases in the mitogenic responses
of normal human melanocytes (Funasaka et al, 1992; BoÈhm et al,
1995). We have demonstrated that human melanocyte cultures can
be established and maintained in a medium supplemented with ET-
1, bFGF, and a-MSH (Swope et al, 1995). All three factors are
known to be synthesized by human keratinocytes, and thus can
function as paracrine regulators of melanocytes in situ (Halaban et al,
1988; Imokawa et al, 1992; Schauer et al, 1994; Chakraborty et al,
1996). We found that ET-1 and bFGF, but not a-MSH or
forskolin, induce the phosphorylation and hence the activation of
ERK1/2 (Fig 1a) (Swope et al, 1995). Others have previously
reported similar effects of bFGF and ET-1 (BoÈhm et al, 1995). The
concentrations of a-MSH and forskolin used in these experiments
resulted in signi®cant increases in intracellular cAMP levels (Suzuki
et al, 1996; our unpublished results). Others have reported that a-
MSH at a concentration of 1 mM phosphorylates CREB (Price et
al, 1998). The biologic relevance of this result is in question, as this
concentration of a-MSH cannot be achieved physiologically.
CREB is known as a Ca2+/cAMP regulated transcription factor
that is activated in response to a variety of growth factors (Gonzalez
and Montminy, 1989; Sheng et al, 1991; Wood et al, 1992; Xing
et al, 1996). Our current results reveal that bFGF, ET-1, and TPA
phosphorylate the ERK1/2 substrate p90rsk and its substrate CREB
(Figs 1 and 4). a-MSH, forskolin, or dbcAMP do not produce this
effect, however (Fig 1). We have concluded that phosphorylation
of CREB upon treatment with ET-1 or bFGF is dependent on
tyrosine kinase, PKC, and intracellular calcium mobilization, as
phosphorylation could be inhibited by tyrphostin A, bisindolylma-
leimide, or BAPTA/AM, respectively (Figs 3b, 4b, 5b). In human
melanocytes, phosphorylation of CREB was inhibited by the MEK
inhibitor PD 98059, suggesting that CREB is a downstream target
for ERK1/2 that is activated by mitogenic signals (Fig 1d).
The results with normal human melanocytes are different from
those obtained using PC12 cells, which responded to treatment
with cAMP inducers or cAMP analogs with activation of the MAP
kinase ERK1 and phosphorylation of p90rsk and CREB (Gonzalez
and Montminy, 1989; Wood et al, 1992). Increasing evidence,
Figure 5. Signi®cance of tyrosine kinase in stimulating p90rsk and
CREB phosphorylation. (a) Western blot analysis of p90rsk was carried
out on melanocytes that were treated with 0.1 nM ET-1 and/or 5 or
50 mM tyrphostin A25 (Tyr) for 40 min. (b) Phosphorylated CREB was
investigated in melanocytes that were treated with 0.1 nM ET-1 and
100 mM tyrphostin A25 for 40 min.
Figure 6. Effect of UVB on the MAP kinases ERK1/2, p38, and
JNK/SAPK. (a) ERK1/2 was detected in melanocytes that were
irradiated with 0, 21, or 28 mJ per cm2 UVB, or treated with 0.1 nM
ET-1 as a positive control. All groups were extracted 30 min after UVB
exposure or ET-1 treatment, and phospho total ERK1/2 was detected
by Western blotting as described in Fig 1(a). The second lane represents
pERK1/2 control and the last lane represents total ERK1/2 control. (b)
For detection of p38, melanocytes were irradiated with 0, 21, or 28 mJ
per cm2 UVB and were extracted 30 min after UVB exposure. (c) For
detection of phospho and total JNK/SAPK, melanocytes were irradiated
with 21 mJ per cm2 UVB or treated with 0.1 nM ET-1, and cell
extracts were prepared 30 min after treatment and used for Western blot
analysis.
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however, suggests that PKA is not the major CREB kinase in many
cell types, including PC12 cells and B lymphocytes (Hirata et al,
1995; Xie et al, 1996; Deak et al, 1998; Pierrat et al, 1998). The
results using human melanocytes differ from those obtained using
mouse B16 melanoma cells, which responded to cAMP-inducing
agents with activation of ERK1 (Englaro et al, 1995). The
difference between the two types of melanocytes might be
attributed to species differences as well as to the malignant
phenotype of B16 melanoma.
We suggest that a-MSH is a true melanogenic factor and a
comitogen, as on its own it is capable of increasing melanogenesis,
yet it requires the presence of bFGF and ET-1 to stimulate
melanocyte proliferation (Abdel-Malek et al, 1995; Swope et al,
1995; Suzuki et al, 1996). We found that the mitogens ET-1 and
bFGF, but not a-MSH or forskolin, phosphorylate ERK1/2,
p90rsk, and CREB (Figs 1, 2), suggesting that this pathway is
primarily associated with mitogenic stimulation in normal human
melanocytes.
It is becoming evident that CREB phosphorylation occurs also
in response to stress, such as chemical stress, exposure to UVC
radiation, or hypoxia (BoÈhm et al, 1995; Tan et al, 1996; Iordanov
et al, 1997; Beitner-Johnson and Millhorn, 1998). It has been
shown that UVC radiation activates ERK1/2 in epidermal
keratinocytes (Dhanwada et al, 1995). Irradiation of human
melanocytes with UVB, however, did not result in ERK1/2
phosphorylation and activation, as determined by Western blotting
and in-gel kinase assay, respectively (Fig 6a) (Medrano et al, 1995).
Exposure of human melanocytes to UVB but not to ET-1 resulted
in the phosphorylation of the stress-induced MAP kinases p38 and
JNK/SAPK (Fig 6b, c). Upstream effectors that selectively activate
JNK/SAPK and p38 but not ERK1/2 include the Rho GTPases,
particularly Rac1/2 and Cdc42 (Coso et al, 1995; Minden et al,
1995). Irradiation with UVB induced the phosphorylation of
CREB but not p90rsk, and CREB phosphorylation could be
partially inhibited by the p38 inhibitor SB 203580 (Fig 7a, b). Our
results are consistent with previous ®ndings that UVB is a potent
inducer of JNK/SAPK but a poor activator of ERK1/2 in human
keratinocytes (Assefa et al, 1997). More recently, it was reported
that UVB irradiation of human HaCaT keratinocytes results in
phosphorylation of p38, JNK/SAPK, but not ERK1/2 (Shimizu et
al, 1999). In this study, it was demonstrated that p38 plays an
important role in the UVB-induced apoptosis. Using normal
human keratinocyte cultures, we observed lack of ERK1/2
activation but phosphorylation of p38 and JNK/SAPK in response
to UVB (Pereira et al, 2000). These results suggest that the latter
two forms of MAP kinases are involved in the UVB signaling
pathway in the human epidermis.
We conclude that mitogens and stress induce CREB
phosphorylation by activating at least two distinct pathways
(Fig 8). The growth-factor-induced CREB phosphorylation is
dependent on the activation of ERK1/2 and p90rsk. The stress-
induced CREB phosphorylation involves the MAP kinase p38
and possibly its substrate MAPKAP kinase-2, as well as JNK/
SAPK (Tan et al, 1996; Iordanov et al, 1997). Recently, p38
was shown to activate two CREB kinases, RSK-B and
mitogen- and stress-induced protein kinase-1 (MSK1) (Deak et
al, 1998; Pierrat et al, 1998). Future experiments will identify
the downstream targets of PKA, and further elucidate the
upstream kinase(s) and signaling pathways involved in the UVB-
induced CREB phosphorylation. Activation of CREB is
postulated to be part of a survival mechanism in melanoma
cells (Jean et al, 1998). Therefore, it is conceivable that CREB
phosphorylation by UVB may be a way to limit the UVB-
induced apoptosis and promote cell survival.
Figure 7. Effect of UVB on p90rsk and CREB. (a) For the detection
of p90rsk, melanocytes were irradiated with 0 (control), 7, 14, or 28 mJ
per cm2 UVB or treated with 8 nM TPA, and cell extracts were
prepared 10 or 30 min after treatment. (b) For detection of phospho and
total CREB, melanocytes were irradiated with 0 (control), 7, 14, or 28
mJ per cm2 UVB, with or without subsequent treatment with 50 mM
SB 203580, p38 inhibitor, and cell extracts were prepared for Western
blotting 30 min thereafter.
Figure 8. Summary of the signaling pathways that lead to
activation of CREB in melanocytes in response to mitogens or
UVB. (a) Mitogens; (b) UVB.
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